Skip to content
Disclosery

EXANE DERIVATIVES: GFF position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of EXANE DERIVATIVES on GFF, newest first. How the timeline and the estimate are built.

EXANE DERIVATIVES held 7,702 GFF shares at 2022-06-30 per its 13F-HR filed 2022-07-12.

the latest 13F is the newest step

  1. period ended2022-06-30
    13F 7,702 shares
    Change vs previous 13F -500 shares

    0.12% of the 13F portfolio, value $215,843.

    13F-HR 0001623883-22-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2022-03-31
    13F 8,202 shares
    Change vs previous 13F -3,556 shares

    0.05% of the 13F portfolio, value $164,276.

    13F-HR 0001623883-22-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2021-12-31
    13F 11,758 shares
    Change vs previous 13F -371 shares

    0.08% of the 13F portfolio, value $334,856.

    13F-HR 0001623883-22-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2021-09-30
    13F 12,129 shares
    Change vs previous 13F +2,449 shares

    0.07% of the 13F portfolio, value $298,363.

    13F-HR 0001623883-21-000008 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2021-06-30
    13F 9,680 shares
    Change vs previous 13F not available

    0.06% of the 13F portfolio, value $237,832.

    13F-HR 0001623883-21-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).